Advertisement
Logo
Search for

Volume 57, Issue 12, Pages 1636-1644 (December 2008)


View previous. 5 of 23 View next.

The effect of strawberries in a cholesterol-lowering dietary portfolio

David J.A. JenkinsabcdCorresponding Author Informationemail address, Tri H. Nguyenac, Cyril W.C. Kendallach, Dorothea A. Faulknerac, Balachandran Bashyamac, In Joo Kime, Chris Irelandac, Darshna Patelac, Edward Vidgenac, Andrea R. Josseac, Howard D. Sessof, Britt Burton-Freemang, Robert G. Josseabcd, Lawrence A. Leiterabcd, William Singerabd

Received 27 February 2008; accepted 24 July 2008.

Abstract 

Effective diets reduce blood lipids and oxidative damage, both of which have been linked to the complications of diabetes and coronary heart disease. Our objective was to assess the effect of adding strawberries, as a source of antioxidants, to improve the antioxidant effect of a cholesterol-lowering diet (dietary portfolio). To this end, 28 hyperlipidemic subjects who had followed the dietary portfolio consisting of soy, viscous fiber, plant sterol, and nuts for a mean of 2.5 years were randomized to receive supplements of strawberries (454 g/d, 112 kcal) or additional oat bran bread (65 g/d, 112 kcal, ≈2 g β-glucan) (control) in a randomized 1-month crossover study with a 2-week washout. Strawberry supplementation resulted in a greater reduction in oxidative damage to low-density lipoprotein (LDL) measured as thiobarbituric acid–reactive substances in the LDL fraction (P = .014). At the end of the strawberry period, reductions in LDL cholesterol and in the ratio of total to high-density lipoprotein cholesterol were maintained close to 1-year values at −13.4% ± 2.1% and −15.2% ± 1.7%, respectively (P < .001), and were similar to the post–oat bran bread values. Strawberries also improved the palatability of the diet. We conclude that strawberry supplementation reduced oxidative damage to LDL while maintaining reductions in blood lipids and enhancing diet palatability. Added fruit may improve the overall utility of diets designed to lower coronary heart disease risk.

a Clinical Nutrition & Risk Factor Modification Center, St Michael's Hospital, Toronto, Ontario, Canada, M5C 2T2

b Department of Medicine, Division of Endocrinology and Metabolism, St Michael's Hospital, Toronto, Ontario, Canada, M5C 2T2

c Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 3E2

d Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada M5G 2C4

e Department of Internal Medicine, Busan, 602-739 South Korea

f Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA

g Department of Nutrition, University of California, Davis, CA 60501, USA

h College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5C9

Corresponding Author InformationCorresponding author. Tel.: +1 416 978 4752; fax: +1 416 978 5310.

 Trial registration: ClinicalTrials.gov; NCT00345722.

PII: S0026-0495(08)00269-2

doi:10.1016/j.metabol.2008.07.018


View previous. 5 of 23 View next.

Advertisement